SCHEMBL22700670

SCHEMBL22700670

O=C(Nc1ccccc1N1CCCCCC1)c1ccncc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.71
NPSR1 Q6W5P4 4/20 0.71
MEN1 O00255 3/20 0.71
TDP1 Q9NUW8 1/20 0.71
POLB P06746 1/20 0.69
MMP1 P03956 1/20 0.67
TSHR P16473 3/20 0.66
MAPT P10636 3/20 0.66
LMNA P02545 2/20 0.66
KDR P35968 1/20 0.66
SRPK2 P78362 1/20 0.66
SRPK1 Q96SB4 1/20 0.66
SRPK3 Q9UPE1 1/20 0.66
ALDH1A1 P00352 1/20 0.66
GAA P10253 2/20 0.64
PIM1 P11309 3/20 0.63
MAPK1 P28482 2/20 0.63
PIM3 Q86V86 2/20 0.63
PIM2 Q9P1W9 1/20 0.63
CSF1R P07333 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485343 1.00 KMT2A (0.71) KMT2ANPSR1MEN1TDP1POLB
Hydrochloric Acid SCHEMBL2023240 0.85 POLB (0.76) KMT2ANPSR1MEN1TDP1POLB
SCHEMBL20198496 0.83 CDK4 (0.69) KMT2ANPSR1MEN1TDP1TSHR
SCHEMBL13167001 0.82 KMT2A (0.97) KMT2ANPSR1MEN1TDP1POLB
SCHEMBL3485720 0.82 SRPK1 (0.74) KMT2ANPSR1MEN1TDP1POLB
SCHEMBL3485243 0.82 KDR (0.71) KMT2AMEN1POLBMAPTKDR
SCHEMBL22700680 0.82 SRPK1 (0.74) KMT2ANPSR1MEN1TDP1POLB
SCHEMBL3485238 0.82 KDR (0.71) KMT2ANPSR1MEN1POLBTSHR
SCHEMBL31187476 0.82 SRPK1 (0.74) KMT2ANPSR1MEN1TDP1POLB
SCHEMBL1110476 0.80 SRPK1 (1.00) KMT2ANPSR1MEN1POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210100781-A1 TUMOR SUPPRESSION KYOTO UNIVERSITY (JP) 2021-04-08 US disclosed
WO-2020235672-A1 PHARMACEUTICAL COMPOSITION FOR ALZHEIMER'S DISEASE 国立大学法人京都大学 (JP) 2020-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210100781-A1 TUMOR SUPPRESSION TSG101, TP53, VHL KMT2A 2293/4885NPSR1 1962/4885MEN1 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.